FDA Approved: BICALUTAMIDE — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approves Sun Pharmaceutical's generic bicalutamide through an original ANDA, providing a generic antiandrogen option for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Bicalutamide (generic) (Bicalutamide)

Snippet

ORIG AP for BICALUTAMIDE (BICALUTAMIDE)